Literature DB >> 31203462

An Update on Diagnosis and Classification of Axial Spondyloarthritis.

Victoria Navarro-Compán1.   

Abstract

PURPOSE OF REVIEW: To summarize the most relevant recent progress to diagnose and classify patients with axial spondyloarthritis (axSpA). RECENT
FINDINGS: A substantial proportion of new studies focused on the diagnosis and classification of patients with axSpA. Efforts have been concentrated on setting the best strategy to refer patients with suspected axSpA and evaluating the utility of different tools during the diagnostic work-up, especially of imaging techniques. On top of this, researchers have worked on addressing some concerns raised about the employment of the Assessment of SpondyloArthritis international Society classification criteria, especially those related to the validity and misuse of the criteria, providing valuable data on this regard. Recent findings emphasize that classification should serve a completely different purpose than diagnosis. In addition, they highlight the importance to consider the limitations for imaging acquisition, the appropriate context, and differential diagnosis when interpreting imaging findings during the diagnostic work-up of patients with suspected axSpA.

Entities:  

Keywords:  Ankylosing spondylitis; Axial spondyloarthritis; Classification; Diagnosis; Non-radiographic axial spondyloarthritis; Review

Year:  2019        PMID: 31203462     DOI: 10.1007/s11926-019-0838-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  36 in total

Review 1.  How to measure disease activity in axial spondyloarthritis?

Authors:  Pedro Machado; Désirée van der Heijde
Journal:  Curr Opin Rheumatol       Date:  2011-07       Impact factor: 5.006

Review 2.  2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.

Authors:  Désirée van der Heijde; Sofia Ramiro; Robert Landewé; Xenofon Baraliakos; Filip Van den Bosch; Alexandre Sepriano; Andrea Regel; Adrian Ciurea; Hanne Dagfinrud; Maxime Dougados; Floris van Gaalen; Pál Géher; Irene van der Horst-Bruinsma; Robert D Inman; Merryn Jongkees; Uta Kiltz; Tore K Kvien; Pedro M Machado; Helena Marzo-Ortega; Anna Molto; Victoria Navarro-Compàn; Salih Ozgocmen; Fernando M Pimentel-Santos; John Reveille; Martin Rudwaleit; Jochen Sieper; Percival Sampaio-Barros; Dieter Wiek; Jürgen Braun
Journal:  Ann Rheum Dis       Date:  2017-01-13       Impact factor: 19.103

Review 3.  Understanding How the Diagnostic Delay of Spondyloarthritis Differs Between Women and Men: A Systematic Review and Metaanalysis.

Authors:  Vega Jovaní; Mar Blasco-Blasco; M Teresa Ruiz-Cantero; Eliseo Pascual
Journal:  J Rheumatol       Date:  2016-12-15       Impact factor: 4.666

4.  Age at symptom onset in ankylosing spondylitis: is there a gender difference?

Authors:  Adrian Ciurea; Almut Scherer; Ulrich Weber; Regula Neuenschwander; Giorgio Tamborrini; Pascale Exer; Jürg Bernhard; Peter M Villiger; Rudolf Kissling; Beat A Michel; Daniel Stekhoven
Journal:  Ann Rheum Dis       Date:  2014-08-07       Impact factor: 19.103

5.  Comparison of MRI with radiography for detecting structural lesions of the sacroiliac joint using CT as standard of reference: results from the SIMACT study.

Authors:  Kay-Geert A Hermann; Torsten Diekhoff; Juliane Greese; Carsten Schwenke; Denis Poddubnyy; Bernd Hamm; Joachim Sieper
Journal:  Ann Rheum Dis       Date:  2017-03-10       Impact factor: 19.103

6.  Are Ultrasound Findings Similar in Patients with Axial Spondyloarthritis and in Athlete Entheses?

Authors:  Marie-Alix Lanfranchi; Olivier Leluc; Alice Tavano; Cécile Wormser; Sophie Morange; Christophe Chagnaud; Vincent Pradel; Pierre Lafforgue; Thao Pham
Journal:  J Rheumatol       Date:  2017-03-01       Impact factor: 4.666

Review 7.  Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis.

Authors:  Alexandre Sepriano; Roxana Rubio; Sofia Ramiro; Robert Landewé; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2017-02-08       Impact factor: 19.103

8.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

Review 9.  Recent Advances in Imaging of the Axial Skeleton in Spondyloarthritis for Diagnosis, Assessment of Treatment Effect, and Prognostication.

Authors:  Susanne Juhl Pedersen; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2015-09       Impact factor: 4.592

10.  EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice.

Authors:  P Mandl; V Navarro-Compán; L Terslev; P Aegerter; D van der Heijde; M A D'Agostino; X Baraliakos; S J Pedersen; A G Jurik; E Naredo; C Schueller-Weidekamm; U Weber; M C Wick; P A C Bakker; E Filippucci; P G Conaghan; M Rudwaleit; G Schett; J Sieper; S Tarp; H Marzo-Ortega; M Østergaard
Journal:  Ann Rheum Dis       Date:  2015-04-02       Impact factor: 19.103

View more
  5 in total

1.  Primary care physician perspectives on screening for axial spondyloarthritis: A qualitative study.

Authors:  Kate L Lapane; Divya Shridharmurthy; Sara Khan; Daniel Lindstrom; Ariel Beccia; Esther Yi; Jonathan Kay; Catherine Dube; Shao-Hsien Liu
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

2.  Secukinumab-induced Raynaud's phenomenon: first report in the literature.

Authors:  Senol Kobak
Journal:  Ther Adv Drug Saf       Date:  2020-02-22

Review 3.  A glance into the future of diagnosis and treatment of spondyloarthritis.

Authors:  Victoria Navarro-Compán; Joerg Ermann; Denis Poddubnyy
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-07-22       Impact factor: 3.625

4.  Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation.

Authors:  Jeonghyeon Moon; Seon-Yeong Lee; Hyun Sik Na; A Ram Lee; Keun-Hyung Cho; Jeong Won Choi; Sung-Hwan Park; Mi-La Cho
Journal:  Front Immunol       Date:  2022-08-17       Impact factor: 8.786

5.  Axial spondyloarthritis 10 years on: still looking for the lost tribe.

Authors:  Rosemarie Barnett; Thomas Ingram; Raj Sengupta
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.